All Akkermansia muciniphila articles – Page 2
-
NewsEarly life exposure to common chemical permanently disrupts gut microbiome
A study in mice finds that by significantly disrupting the gut microbiome, early life exposure to persistent organic pollutants influenced the development of metabolic disorder in adult mice.
-
NewsCranberry extracts could boost microbiota and counter cardiometabolic diseases
Cranberry extracts appear to improve intestinal microbiota and help prevent chronic diseases such as diabetes and cardiovascular diseases, according to a study that reported beneficial effects after only four days of use.
-
NewsGenomic ‘tweezer’ ushers in a new era of precision in microbiome research
Researchers have unveiled mEnrich-seq—an innovative method designed to substantially enhance the specificity and efficiency of research into microbiomes, the complex communities of microorganisms that inhabit the human body.
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsNew research reveals gut microbiota link to colitis - and therapetic strategies
Researchers have revealed a new and critical role of Axin1 in regulating intestinal epithelial development and microbial homeostasis.
- Previous Page
- Page1
- Page2
- Next Page